164
report
Giving Smarter: Philanthropic Opportunities to Advance Bipolar Disorder Research
People of all ages, ethnicities, and backgrounds endure the intense shifts in mood and energy level
s bipolar disorder (BD) causes.
+ Read More
report
Framing the Issues: Digital Mental Health in Asia
More than a decade since the World Health Organization declared “no health without mental health,”
its message bears heeding more than ever.
+ Read More
report
Creating a Nonprofit Marketplace for Shelved Drugs: Lessons from a Pilot Project
Many promising medicines, despite strong safety data and pharmaceutical characteristics, are discon
tinued by drug companies for nonscientific reasons, including strategic, organizational, and financial considerations.
+ Read More
report
Moonshots for Youth Mental Health and Well-Being: Exploration of Big Bets and Bold Goals
Good mental health is critical to overall health and well-being, but a cycle of almost endless stre
ssors, stigma, and systemic barriers to accessing quality care have brought America’s collective mental health to a breaking point.
+ Read More
report
Hedging Pipeline Risk in Pharma: FDA Swaps and Annuities
The cost of capital to conduct medical R&D is high because investors must be compensated with s
ignificant returns to offset the risky and long drug-development process.
+ Read More
report
One Mind's 2014 Annual Summit White Paper
At One Mind, we are dedicated to fostering fundamental changes that will radically accelerate the d
evelopment and implementation of improved diagnostics, treatments, and cures for diseases and injuries of the brain – all while eliminating the stigma and
+ Read More
report
Nonprofits: A Growing Force in Drug Development
Shepherding a drug from discovery to the market is a complex process that involves many actors.
report
Patient-Focused Drug Development Meetings: Smart Practices from Community Leaders
FasterCures, a center of the Milken Institute, designed this guide for patient advocacy organizatio
ns that are interested in hosting, or are currently planning, an externally led patient-focused drug development (PFDD)
+ Read More
report
GBM: Giving Smarter
Glioblastoma Multiforme (GBM) is an aggressive malignant brain tumor involving glial cells of the b
rain. At the time of this report, nearly 15,000 people were diagnosed with GBM each year in the United States and Europe.
+ Read More
report
Philanthropic Opportunities for Well-Being in Higher Education
Fear, anxiety and social isolation brought on by the pandemic has exacerbated existing mental healt
h challenges for people on college campuses, and created new ones as online learning expands, key rites of passage are cancelled, and social isolation con
+ Read More
report
Philanthropic Action for America’s Mental Health System
Long before COVID-19 became a pandemic, America’s mental health system was failing to meet the need
s of people requiring care.
+ Read More
report
State Technology and Science Index 2016: Sustaining Americas Innovation Economy
As the Great Recession recedes in our rearview mirrors, it is becoming ever more apparent that inno
vative activities are determining an increasing proportion of the long-term economic growth of cities, metropolitan areas, regions, states, and even natio
+ Read More